TABLE 3.

Healthcare resource utilization, direct medical costs, and clinical outcomes of hospitalized patients with RSV positive.

	Up to 2 years	2–5 years	5–18 years	18–65 years	65+ years
	n = 683	n = 197	n = 31	n = 67	n = 101
Healthcare resource utilization
Patient who received emergency care, n (%)	141 (20.6%)	40 (20.3%)	10 (32.3%)	21 (31.3%)	45 (44.6%)
Hospitalization length (days)
Mean ± SD	9 ± 13	7 ± 10	11 ± 13	20 ± 35	20 ± 25
Median (IQR)	6 (4, 9)	4 (3, 6)	6 (3, 12)	9 (5, 17)	11 (6, 19)
Patient who received critical care, n (%)	154 (22.5%)	32 (16.2%)	15 (48.4%)	18 (26.9%)	38 (37.6%)
Length of stay in critical care unit (days)
Mean ± SD	23 ± 40	19 ± 29	21 ± 26	43 ± 98	21 ± 27
Median (IQR)	9 (5, 24)	8 (3, 18)	11 (4, 33)	11.5 (6, 31)	12.5 (5, 32)
Direct medical costs, USD
Outpatient costs
Mean ± SD	56 ± 56	49 ± 65	76 ± 159	125 ± 330	105 ± 330
Median (IQR)	47 (8, 84)	39 (1, 74)	4 (0, 82)	0 (0, 101)	0 (0, 116)
Emergency care costs
Mean ± SD	30 ± 30	30 ± 39	92 ± 94	253 ± 163	255 ± 165
Median (IQR)	26 (2, 44)	27 (2, 54)	63 (49, 88)	236 (148, 364)	228 (110, 366)
Inpatient costs
Mean ± SD	1544 ± 4605	1188 ± 3344	4902 ± 11,436	6766 ± 13,816	4615 ± 8056
Median (IQR)	713 (438, 1111)	526 (316, 861)	985 (394, 1815)	1916 (808, 6141)	2019 (768, 4725)
Total hospitalization costs (outpatient + inpatient + emergency care costs)
Mean ± SD	1605 ± 4598	1245 ± 3339	5007 ± 11,401	6970 ± 13,763	4833 ± 8007
Median (IQR)	780 (488, 1185)	592 (377, 899)	1004 (483, 1862)	2211 (1062, 6962)	2231 (1250, 4989)
Clinical outcome, n (%)
Patients with respiratory complications	439 (64.3%)	106 (53.8%)	11 (35.5%)	22 (32.8%)	42 (41.6%)
Bronchiolitis	87 (12.7%)	11 (5.6%)	0 (0.0%)	0 (0.0%)	1 (1.0%)
Pneumonia	374 (54.8%)	98 (49.7%)	11 (35.5%)	20 (29.9%)	38 (37.6%)
Death among hospitalized patients	20 (2.9%)	5 (2.5%)	6 (19.4%)	19 (28.4%)	27 (26.7%)

Note: 1 USD = 31.98 Thai Baht.

Abbreviations: RSV, respiratory syncytial virus; USD, US dollars.